OBJECTIVE: To study the profile of hospitalizations due to COVID-19 in the Unified Health System (SUS) in Brazil and to identify factors associated with in-hospital mortality related to the disease. METHODS: Cross-sectional study, based on secondary data on COVID-19 hospitalizations that occurred in the SUS between late February through June. Patients aged 18 years or older with primary or secondary diagnoses indicative of COVID-19 were included. Bivariate analyses were performed and generalized linear mixed models (GLMM) were estimated with random effects intercept. The modeling followed three steps, including: attributes of the patients; elements of the care process; and characteristics of the hospital and place of hospitalization. RESULTS: 89,405 hospitalizations were observed, of which 24.4% resulted in death. COVID-19 patients hospitalized in the SUS were predominantly male (56.5%) with a mean age of 58.9 years. The length of stay ranged from less than 24 hours to 114 days, with a mean of 6.9 (±6.5) days. Of the total number of hospitalizations, 22.6% reported ICU use. The odds on in-hospital death were 16.8% higher among men than among women and increased with age. Black individuals had a higher likelihood of death. The behavior of the Charlson and Elixhauser indices was consistent with the hypothesis of a higher risk of death among patients with comorbidities, and obesity had an independent effect on increasing this risk. Some states, such as Amazonas and Rio de Janeiro, had a higher risk of in-hospital death from COVID-19. The odds on in-hospital death were 72.1% higher in municipalities with at least 100,000 inhabitants, though being hospitalized in the municipality of residence was a protective factor. CONCLUSION: There was broad variation in COVID-19 in-hospital mortality in the SUS, associated with demographic and clinical factors, social inequality, and differences in the structure of services and quality of health care.
OBJECTIVE: To study the profile of hospitalizations due to COVID-19 in the Unified Health System (SUS) in Brazil and to identify factors associated with in-hospital mortality related to the disease. METHODS: Cross-sectional study, based on secondary data on COVID-19 hospitalizations that occurred in the SUS between late February through June. Patients aged 18 years or older with primary or secondary diagnoses indicative of COVID-19 were included. Bivariate analyses were performed and generalized linear mixed models (GLMM) were estimated with random effects intercept. The modeling followed three steps, including: attributes of the patients; elements of the care process; and characteristics of the hospital and place of hospitalization. RESULTS: 89,405 hospitalizations were observed, of which 24.4% resulted in death. COVID-19patients hospitalized in the SUS were predominantly male (56.5%) with a mean age of 58.9 years. The length of stay ranged from less than 24 hours to 114 days, with a mean of 6.9 (±6.5) days. Of the total number of hospitalizations, 22.6% reported ICU use. The odds on in-hospital death were 16.8% higher among men than among women and increased with age. Black individuals had a higher likelihood of death. The behavior of the Charlson and Elixhauser indices was consistent with the hypothesis of a higher risk of death among patients with comorbidities, and obesity had an independent effect on increasing this risk. Some states, such as Amazonas and Rio de Janeiro, had a higher risk of in-hospital death from COVID-19. The odds on in-hospital death were 72.1% higher in municipalities with at least 100,000 inhabitants, though being hospitalized in the municipality of residence was a protective factor. CONCLUSION: There was broad variation in COVID-19 in-hospital mortality in the SUS, associated with demographic and clinical factors, social inequality, and differences in the structure of services and quality of health care.
Authors: Jussara A Oliveira Baggio; Ana Luiza Exel; Ana Carolina do Nascimento Calles; Vinicius Minatel Journal: Arq Bras Cardiol Date: 2021-11 Impact factor: 2.000
Authors: Veridiana Baldon Dos Santos; Airton Tetelbom Stein; Sofia Louise Santin Barilli; Andresa Fontoura Garbini; Rafaela Charão de Almeida; Daniela Dos Reis Carazai; Fernanda Costa Dos Santos; Raquel Lutkmeier; Isadora Helena Greve; André Klafke; Ketlen Monteiro Mussart; Estefania Inez Wittke Journal: Rev Inst Med Trop Sao Paulo Date: 2022-02-25 Impact factor: 1.846
Authors: Helidea de Oliveira Lima; Leopoldo Muniz da Silva; Arthur de Campos Vieira Abib; Leandro Reis Tavares; Daniel Wagner de Castro Lima Santos; Ana Claudia Lopes Fernandes de Araújo; Laise Pereira Moreira; Saullo Queiroz Silveira; Vanessa de Melo Silva Torres; Deborah Simões; Ramiro Arellano; Anthony M-H Ho; Glenio B Mizubuti Journal: Sci Rep Date: 2022-04-16 Impact factor: 4.379
Authors: William K Gray; Annakan V Navaratnam; Jamie Day; Pratusha Babu; Shona Mackinnon; Ini Adelaja; Sam Bartlett-Pestell; Chris Moulton; Cliff Mann; Anna Batchelor; Michael Swart; Chris Snowden; Philip Dyer; Michael Jones; Martin Allen; Adrian Hopper; Gerry Rayman; Partha Kar; Andrew Wheeler; Sue Eve-Jones; Kevin J Fong; John T Machin; Julia Wendon; Tim W R Briggs Journal: EClinicalMedicine Date: 2021-04-26
Authors: Mayra Monteiro de Oliveira; Trevon L Fuller; Claudia R Gabaglia; Mary Catherine Cambou; Patricia Brasil; Zilton Farias Meira de Vasconcelos; Karin Nielsen-Saines Journal: Prev Med Date: 2021-12-22 Impact factor: 4.018